Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells. (27th December 2019)
- Record Type:
- Journal Article
- Title:
- Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells. (27th December 2019)
- Main Title:
- Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells
- Authors:
- Choi, Kyung‐Ah
Park, Han‐Kyul
Hwang, Insik
Jeong, Hyesun
Park, Hang‐Soo
Jang, Ahyoung
Namkung, Yong
Hyun, Donghun
Lee, Seulbee
Yoo, Byung Min
Kwon, Han‐Jin
Seol, Ki‐Cheon
Kim, Jeong‐Ok
Hong, Sunghoi - Abstract:
- Abstract: Pluripotent stem cells (PSCs) can serve as an unlimited cell source for transplantation therapies for treating various devastating diseases, such as cardiovascular diseases, diabetes, and Parkinson's disease. However, PSC transplantation has some associated risks, including teratoma formation from the remaining undifferentiated PSCs. Thus, for successful clinical application, it is essential to ablate the proliferative PSCs before or after transplantation. In this study, neural stem cell‐derived conditioned medium (NSC‐CM) inhibited the proliferation of PSCs and PSC‐derived neural precursor (NP) cells without influencing the potential of PSC‐NP cells to differentiate into neurons in vitro and prevented teratoma growth in vivo. Moreover, we found that the NSC‐CM remarkably decreased the expression levels of Oct4 and cyclin D1 that Oct4 directly binds to and increased the cleaved‐caspase 3‐positive cell death through the DNA damage response in PSCs and PSC‐NPs. Interestingly, we found that NSCs distinctly secreted the tissue inhibitor of metalloproteinase (TIMP)‐1 and TIMP‐2 proteins. These proteins suppressed not only the proliferation of PSCs in cell culture but also teratoma growth in mice transplanted with PSCs through inhibition of matrix metalloproteinase (MMP)‐2 and MMP‐9 activity. Taken together, these results suggest that the TIMP proteins may improve the efficacy and safety of the PSC‐based transplantation therapy. Abstract : Pluripotent stem cells (PSCs)Abstract: Pluripotent stem cells (PSCs) can serve as an unlimited cell source for transplantation therapies for treating various devastating diseases, such as cardiovascular diseases, diabetes, and Parkinson's disease. However, PSC transplantation has some associated risks, including teratoma formation from the remaining undifferentiated PSCs. Thus, for successful clinical application, it is essential to ablate the proliferative PSCs before or after transplantation. In this study, neural stem cell‐derived conditioned medium (NSC‐CM) inhibited the proliferation of PSCs and PSC‐derived neural precursor (NP) cells without influencing the potential of PSC‐NP cells to differentiate into neurons in vitro and prevented teratoma growth in vivo. Moreover, we found that the NSC‐CM remarkably decreased the expression levels of Oct4 and cyclin D1 that Oct4 directly binds to and increased the cleaved‐caspase 3‐positive cell death through the DNA damage response in PSCs and PSC‐NPs. Interestingly, we found that NSCs distinctly secreted the tissue inhibitor of metalloproteinase (TIMP)‐1 and TIMP‐2 proteins. These proteins suppressed not only the proliferation of PSCs in cell culture but also teratoma growth in mice transplanted with PSCs through inhibition of matrix metalloproteinase (MMP)‐2 and MMP‐9 activity. Taken together, these results suggest that the TIMP proteins may improve the efficacy and safety of the PSC‐based transplantation therapy. Abstract : Pluripotent stem cells (PSCs) can serve as an unlimited cell source for transplantation therapies for treating various devastating diseases, but PSC transplantation has a teratoma formation risk. Neural stem cell‐derived conditioned medium (NSC‐CM) prevented teratoma growth in vivo. NSCs distinctly secreted the tissue inhibitor of metalloproteinase TIMP proteins, which suppressed teratoma growth in mice transplanted with PSCs. … (more)
- Is Part Of:
- Stem cells. Volume 38:Number 4(2020)
- Journal:
- Stem cells
- Issue:
- Volume 38:Number 4(2020)
- Issue Display:
- Volume 38, Issue 4 (2020)
- Year:
- 2020
- Volume:
- 38
- Issue:
- 4
- Issue Sort Value:
- 2020-0038-0004-0000
- Page Start:
- 516
- Page End:
- 529
- Publication Date:
- 2019-12-27
- Subjects:
- neural stem cell‐derived conditioned medium -- pluripotent stem cells -- teratoma -- tissue inhibitor of metalloproteinase -- transplantation therapy
Cloning -- Periodicals
Clone cells -- Periodicals
Stem cells -- Periodicals
Cell Differentiation -- Periodicals
Cell Division -- Periodicals
Clone Cells -- Periodicals
Hematopoietic Stem Cells -- Periodicals
Stem Cells -- Periodicals
571.84 - Journal URLs:
- https://academic.oup.com/stmcls ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/stem.3132 ↗
- Languages:
- English
- ISSNs:
- 1066-5099
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8464.133510
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21505.xml